ResultsIQ › Latest results › Vimta Labs Limited
Vimta Labs Limited Q2 FY27 earnings call summary
NSE: VIMTALABS · BSE: 524394
Earnings call of 30 Oct 2026, summarised by AI from the filing.
Vimta Labs' Q2 FY27 total income rose 9.9% year-on-year to ₹1,149 million, with revenue broadly flat sequentially and biologics revenue beginning.
Key takeaways
- Sequential flatness Revenue was broadly stable versus Q1 FY27 on longer customer decision cycles and a pharma R&D lull.
- Biologics start Revenue generation from biologics services commenced in Q2 FY27, though the contribution is very modest.
- Margin risk A 100-200 bps EBITDA margin correction is possible medium term as service mix shifts toward biologics.
Vimta Labs Limited Q2 FY27 results
As filed: Revenue ₹112 cr (+10% year on year), EBITDA ₹37.9 cr (+15% year on year), PAT ₹20.6 cr (+3% year on year), EBITDA margin 33.8% (+148 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹109 cr (+11% year on year), EBITDA ₹37.3 cr (+13% year on year), PAT ₹21.0 cr (+11% year on year), EBITDA margin 34.2% (+54 bps). Score 36 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 54 bps year on year. Share price after the results: +11.2% in 30 days (Nifty 500: +0.2%).
- Q4 FY26: Revenue ₹109 cr (+16% year on year), EBITDA ₹39.4 cr (+23% year on year), PAT ₹21.1 cr (+17% year on year), EBITDA margin 36.0% (+199 bps). Score 50 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin rose 199 bps year on year. Share price after the results: +6.6% in 30 days (Nifty 500: −2.9%).
- Q3 FY26: Revenue ₹98.6 cr (+11% year on year), EBITDA ₹34.2 cr (+4% year on year), PAT ₹17.6 cr (−16% year on year), EBITDA margin 34.7% (−236 bps). Score 35 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 236 bps year on year. Revenue fell 3% from last quarter. Revenue rose ₹9.6 cr on a year ago, more than the ₹9.0 cr it added the year before. Share price after the results: −17.6% in 30 days (Nifty 500: +1.5%).
- Q2 FY26: Revenue ₹102 cr (+23% year on year), EBITDA ₹33.0 cr (+18% year on year), PAT ₹20.0 cr (+33% year on year), EBITDA margin 32.4% (−138 bps). Score 52 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 138 bps year on year. Revenue rose ₹19.0 cr on a year ago, more than the ₹11.0 cr it added the year before. Share price after the results: −10.4% in 30 days (Nifty 500: −0.4%).
- Q1 FY26: Revenue ₹98.0 cr (+23% year on year), EBITDA ₹33.0 cr (+43% year on year), PAT ₹19.0 cr (+58% year on year), EBITDA margin 33.7% (+492 bps). Score 66 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was in line with it. EBITDA margin rose 492 bps year on year. Share price after the results: +39.4% in 28 days (Nifty 500: −3.4%).
- Q4 FY25: Revenue ₹94.0 cr (+21% year on year), EBITDA ₹32.0 cr (+28% year on year), PAT ₹18.0 cr (+50% year on year), EBITDA margin 34.0% (+199 bps). Score 65 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 199 bps year on year. Profit fell 14% from last quarter. Share price after the results: −4.5% in 30 days (Nifty 500: +3.1%).
- Q3 FY25: Revenue ₹90.0 cr (+10% year on year), EBITDA ₹34.0 cr (+48% year on year), PAT ₹22.0 cr (+120% year on year), EBITDA margin 37.8% (+973 bps). Score 70 of 100, Above trend. Revenue and EBITDA growth were above the company's own trend; profit growth was well above it. EBITDA margin rose 973 bps year on year.
Past price moves after results do not indicate future moves. Not a recommendation.
Vimta Labs Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (30 Oct 2026), Results deck (30 Oct 2026), Results press release (30 Oct 2026)
- Q1 FY27: Earnings call (20 Jul 2026), Results deck (20 Jul 2026), Results press release (20 Jul 2026)
- Q4 FY26: Earnings call (6 May 2026), Results deck (6 May 2026), Results press release (6 May 2026)
- Q3 FY26: Earnings call (28 Jan 2026), Results deck (28 Jan 2026), Results press release (28 Jan 2026)
- Q2 FY26: Earnings call (3 Nov 2025), Results deck (3 Nov 2025), Results press release (3 Nov 2025)
- Q1 FY26: Earnings call (21 Jul 2025), Results deck (17 Jul 2025), Results deck (17 Jul 2025), Results deck (18 Jul 2025), Results press release (17 Jul 2025)
- Q4 FY25: Earnings call (28 Apr 2025), Results deck (28 Apr 2025), Results deck (28 Apr 2025), Results press release (28 Apr 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.